Haleon (HLN) Exchange Rate Effect (2021 - 2023)
Haleon (HLN) posted Exchange Rate Effect of -$41.0 million for Q4 2023, down 258.72% on a QoQ basis from $25.8 million in Q4 2022, and down 258.72% year-over-year from $25.8 million in Q4 2022.
Haleon (HLN) Exchange Rate Effect (2021 - 2023) Analysis & Trends
Haleon's Exchange Rate Effect history runs 3 years deep, the most recent figure standing at -$41.0 million for Q4 2023.
- Quarterly Exchange Rate Effect fell 258.72% year-over-year to -$41.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$197194.1 (changed N/A YoY) and the FY2025 annual result came in at -$64.6 million, up 36.02% from the prior year.
- Exchange Rate Effect was -$41.0 million for Q4 2023 at Haleon, down from $25.8 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $27.1 million in Q3 2022 and bottomed at -$41.0 million in Q4 2023.
- A 3-year average of -$49298.5 and a median of $6.8 million in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 312.7% — and 2023, when it sank 258.72%.
- Haleon's Exchange Rate Effect stood at -$12.1 million in 2021, then soared by 312.7% to $25.8 million in 2022, then sank by 258.72% to -$41.0 million in 2023.
- Business Quant data shows HLN's Exchange Rate Effect at -$41.0 million in Q4 2023, $25.8 million in Q4 2022, and $27.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -40.96 Mn |
| Dec 31, 2023 | -40.96 Mn |
| Dec 31, 2022 | 25.80 Mn |
| Dec 31, 2022 | 25.80 Mn |
| Sep 20, 2022 | 27.09 Mn |
| Sep 20, 2022 | 27.09 Mn |
| Dec 31, 2021 | -12.13 Mn |
| Dec 31, 2021 | -12.13 Mn |